📰 Andera Life Sciences News
Page 3 - Andera Life Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Andera Life Sciences. Real-time updates on events, politics, business and more.
June 8, 2022
/PRNewswire/ -- Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company committed to developing a best-in-class, novel therapy for...
June 8, 2022
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension 08.06.2022 / 14:05 The issuer is solely responsible for the content of th...
May 3, 2022
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs 03.05.2022 / 11:05
May 3, 2022
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs 03.05.2022 / 11:05 The issuer is solely responsible for the content of this announcement. Press Release Andera Partners supports Tubu...
May 3, 2022
Tubulis today announced the successful completion of a €60 million (USD $63 million) Series B financing led by Andera Partners with participation from new investors Evotec and Fund+. All existing investors
April 7, 2022
Andera Partners, a leading European private equity player, through its practice Andera Life Sciences, focused on investments in companies developing breakthrough therapeutics and medical technologies
February 22, 2022
/PRNewswire/ -- TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today...
February 22, 2022
- Financing with equal contribution by an international investor syndicate comprising of Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures - Funds
February 22, 2022
DGAP-News: Andera Partners / Key word(s): Financing Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients 22.02.2022 / 09:30 The issuer is solely responsible for the content of this announcement. PRESS RELE...
February 22, 2022
/PRNewswire/ -- TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today...